Indian diagnostic firm Dr. Lal PathLabs acquires 10% of subsidiary
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL
Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.
Dr. Reddy's unveiled its difluprednate ophthalmic emulsion in the US market for treating inflammation and pain associated with eye surgery.
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
The Covid-19 virus had claimed the lives of 170,000 people over the last eight weeks, after China lifted restrictions imposed during early stages
The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for
Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,